Basic Information
| RNALocate ID: | RLID:11003185 |
| RNA Symbol: | hsa-miR-493-3p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-493-3p |
| RNA ID: | miRBase:MIMAT0003161 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23382797 |
| Tissue/Cell Line: | Brain tissue |
| Method: | Microarray |
| Description: | We performed miRNA expression analysis using a FlexMAP3D instrument by (Luminex Corporation, Austin, TX) and a manufacturer's assay for 312 miRNA (Table S1). Data are collected from Table S1. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:11003186 | Exosome | Plasma | 23663360 |
| RLID:11003187 | Exosome | B cell lymphoma cell lines|EBV-transformed lymphoblastoid B cells | 25242326 |
| RLID:11003188 | Microvesicle | Follicular fluid | 23666971 |
| RLID-D:11000507 | Microvesicle | Fibroblasts|Mesenchymal stem cells | |
| RLID-D:11001313 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-493-3p | Oral squamous cell carcinoma | MNDR-E-MI-54365 |
| MNDR | hsa-miR-493-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-54366 |
| MNDR | hsa-miR-493-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-54367 |
| MNDR | hsa-miR-493-3p | Lymphoma | MNDR-E-MI-54368 |
| MNDR | hsa-miR-493-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-54369 |
| MNDR | hsa-miR-493-3p | Autosomal recessive limb-girdle muscular dystrophy type 2a | MNDR-E-MI-54370 |
| MNDR | hsa-miR-493-3p | Prostate cancer | MNDR-E-MI-54371 |
| MNDR | hsa-miR-493-3p | Gastric cancer | MNDR-E-MI-54372 |
| MNDR | hsa-miR-493-3p | Alzheimer disease | MNDR-E-MI-54373 |
| MNDR | hsa-miR-493-3p | Bladder cancer | MNDR-E-MI-54374 |
| MNDR | hsa-miR-493-3p | Dysautonomia familial | MNDR-E-MI-54375 |
| MNDR | hsa-miR-493-3p | Duchenne muscular dystrophy | MNDR-E-MI-54376 |
| MNDR | hsa-miR-493-3p | Head and neck cancer | MNDR-E-MI-54377 |
| MNDR | hsa-miR-493-3p | Leukemia | MNDR-E-MI-54378 |
| MNDR | hsa-miR-493-3p | Lung cancer | MNDR-E-MI-54379 |
| MNDR | hsa-miR-493-3p | Parkinson disease | MNDR-E-MI-54380 |
| MNDR | hsa-miR-493-3p | Breast cancer | MNDR-E-MI-54381 |
| MNDR | hsa-miR-493-3p | Neuroendocrine neoplasia | MNDR-E-MI-54382 |
| MNDR | hsa-miR-493-3p | Pituitary neoplasms | MNDR-E-MI-54383 |
| MNDR | hsa-miR-493-3p | Pancreatic cancer | MNDR-E-MI-54384 |
| MNDR | hsa-miR-493-3p | Melanoma | MNDR-E-MI-54385 |
| MNDR | hsa-miR-493-3p | Rectum adenocarcinoma | MNDR-E-MI-54386 |
| MNDR | hsa-miR-493-3p | Nephroblastoma | MNDR-E-MI-54387 |
| MNDR | hsa-miR-493-3p | Colon cancer | MNDR-E-MI-54388 |
| MNDR | hsa-miR-493-3p | Colon adenocarcinoma | MNDR-E-MI-54389 |
| MNDR | hsa-miR-493-3p | Ovarian cancer | MNDR-E-MI-54390 |
| MNDR | hsa-miR-493-3p | Prostate adenocarcinoma | MNDR-E-MI-54391 |
| MNDR | hsa-miR-493-3p | Carcinoma ductal breast | MNDR-E-MI-54392 |
| MNDR | hsa-miR-493-3p | Glioblastoma | MNDR-E-MI-54393 |
| MNDR | hsa-miR-493-3p | Malignant glioma | MNDR-E-MI-54394 |
| MNDR | hsa-miR-493-3p | Nemaline myopathy | MNDR-E-MI-54395 |
| MNDR | hsa-miR-493-3p | Epilepsy temporal lobe | MNDR-E-MI-54396 |
| MNDR | hsa-miR-493-3p | Osteosarcoma | MNDR-E-MI-54397 |
| MNDR | hsa-miR-493-3p | Breast carcinoma | MNDR-E-MI-54398 |
| MNDR | hsa-miR-493-3p | Cervical adenocarcinoma | MNDR-E-MI-54399 |
| MNDR | hsa-miR-493-3p | Gastric adenocarcinoma | MNDR-E-MI-54400 |
| MNDR | hsa-miR-493-3p | Lung adenocarcinoma | MNDR-E-MI-54401 |
| MNDR | hsa-miR-493-3p | Adrenocortical carcinoma | MNDR-E-MI-54402 |
| MNDR | hsa-miR-493-3p | Thyroid carcinoma | MNDR-E-MI-54403 |
| MNDR | hsa-miR-493-3p | Ovarian carcinoma | MNDR-E-MI-54404 |
| MNDR | hsa-miR-493-3p | Bladder urothelial carcinoma | MNDR-E-MI-54405 |
| MNDR | hsa-miR-493-3p | Pancreatic adenocarcinoma | MNDR-E-MI-54406 |
| MNDR | hsa-miR-493-3p | Carcinoma renal cell | MNDR-E-MI-54407 |
| MNDR | hsa-miR-493-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-54408 |
| MNDR | hsa-miR-493-3p | Renal clear cell carcinoma | MNDR-E-MI-54409 |
| MNDR | hsa-miR-493-3p | Esophageal cancer | MNDR-E-MI-54410 |
| MNDR | hsa-miR-493-3p | Synovial sarcoma | MNDR-E-MI-54411 |
| MNDR | hsa-miR-493-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-54412 |
| MNDR | hsa-miR-493-3p | Breast invasive carcinoma | MNDR-E-MI-54413 |
| MNDR | hsa-miR-493-3p | B-cell lymphoma | MNDR-E-MI-54414 |
| MNDR | hsa-miR-493-3p | Rheumatoid arthritis | MNDR-E-MI-54415 |
| MNDR | hsa-miR-493-3p | Barrett's adenocarcinoma | MNDR-E-MI-54416 |
| MNDR | hsa-miR-493-3p | Colorectal cancer | MNDR-E-MI-54417 |
| MNDR | hsa-miR-493-3p | Barrett's carcinogenesis | MNDR-E-MI-54418 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | DKK1 | Homo sapiens | RR00442070 |
TOP